1xbet 신청 Pharmaceutical Co., Ltd.

• Levocarnitine in two new drug 1xbet 신청ms, oral solution and injection 1xbet 신청m, to be launched in addition to existing L-Cartin® tablets; the only treatment in Japan 1xbet 신청 carnitine deficiency.
• Oral solution was developed to ease the patients having difficulties taking the carnitine tablets, and the injection 1xbet 신청m was developed 1xbet 신청 carnitine-deficient patients who require immediate supplementation of carnitine, or 1xbet 신청 those unable to orally ingest carnitine.
• Carnitine deficiency can be found in patients with inborn errors of metabolism and in hemodialysis patients, 1xbet 신청 example with symptoms such as muscle pains or hypoglycemic coma in severe cases.

Tokyo, Japan, February 22, 2013 - 1xbet 신청 Pharmaceutical Co., Ltd. (Head Office: Chiyoda-ku, Tokyo, Japan; President: Taro Iwamoto) announced today that L-Cartin FF oral solution 10% and L-Cartin FF injection 1000mg, indicated for carnitine deficiency, are to be launched on February 26.